188 related articles for article (PubMed ID: 30856169)
1. Coupling S-adenosylmethionine-dependent methylation to growth: Design and uses.
Luo H; Hansen ASL; Yang L; Schneider K; Kristensen M; Christensen U; Christensen HB; Du B; Özdemir E; Feist AM; Keasling JD; Jensen MK; Herrgård MJ; Palsson BO
PLoS Biol; 2019 Mar; 17(3):e2007050. PubMed ID: 30856169
[TBL] [Abstract][Full Text] [Related]
2. Tissue and interspecies comparison of catechol-
Jalkanen A; Lassheikki V; Torsti T; Gharib E; Lehtonen M; Juvonen RO
Xenobiotica; 2021 Mar; 51(3):268-278. PubMed ID: 33289420
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Catechol-O-Methyltransferase Inhibitors Tolcapone and Entacapone on Fatty Acid Metabolism in HepaRG Cells.
Grünig D; Felser A; Duthaler U; Bouitbir J; Krähenbühl S
Toxicol Sci; 2018 Aug; 164(2):477-488. PubMed ID: 29688484
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors.
Pinheiro SD; Serrão MP; Silva T; Borges F; Soares-da-Silva P
Eur J Pharmacol; 2019 Mar; 847():53-60. PubMed ID: 30685433
[TBL] [Abstract][Full Text] [Related]
5. S-Adenosylmethionine-dependent methylation in Saccharomyces cerevisiae. Identification of a novel protein arginine methyltransferase.
Niewmierzycka A; Clarke S
J Biol Chem; 1999 Jan; 274(2):814-24. PubMed ID: 9873020
[TBL] [Abstract][Full Text] [Related]
6. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
Napolitano A; Bellini G; Borroni E; Zürcher G; Bonuccelli U
Parkinsonism Relat Disord; 2003 Jan; 9(3):145-50. PubMed ID: 12573869
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester SC; Lambert JD
Carcinogenesis; 2014 Feb; 35(2):365-72. PubMed ID: 24148818
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase: variation in enzyme activity and inhibition by entacapone and tolcapone.
De Santi C; Giulianotti PC; Pietrabissa A; Mosca F; Pacifici GM
Eur J Clin Pharmacol; 1998 May; 54(3):215-9. PubMed ID: 9681662
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases.
Lv X; Wang XX; Hou J; Fang ZZ; Wu JJ; Cao YF; Liu SW; Ge GB; Yang L
Toxicol Appl Pharmacol; 2016 Jun; 301():42-9. PubMed ID: 27089846
[TBL] [Abstract][Full Text] [Related]
10. Regiocomplementary O-Methylation of Catechols by Using Three-Enzyme Cascades.
Siegrist J; Aschwanden S; Mordhorst S; Thöny-Meyer L; Richter M; Andexer JN
Chembiochem; 2015 Dec; 16(18):2576-9. PubMed ID: 26437744
[TBL] [Abstract][Full Text] [Related]
11. Brain catechol-O-methyltransferase (COMT) inhibition by tolcapone counteracts recognition memory deficits in normal and chronic phencyclidine-treated rats and in COMT-Val transgenic mice.
Detrait ER; Carr GV; Weinberger DR; Lamberty Y
Behav Pharmacol; 2016 Aug; 27(5):415-21. PubMed ID: 26919286
[TBL] [Abstract][Full Text] [Related]
12. General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.
Kaakkola S; Gordin A; Männistö PT
Gen Pharmacol; 1994 Sep; 25(5):813-24. PubMed ID: 7835624
[TBL] [Abstract][Full Text] [Related]
13. Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease.
Li LS; Liu CZ; Xu JD; Zheng LF; Feng XY; Zhang Y; Zhu JX
World J Gastroenterol; 2015 Mar; 21(12):3509-18. PubMed ID: 25834315
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Cancer Cell Growth Inhibitory Effects of Table Grape Anthocyanins.
Grimes KL; Stuart CM; McCarthy JJ; Kaur B; Cantu EJ; Forester SC
J Food Sci; 2018 Sep; 83(9):2369-2374. PubMed ID: 30070707
[TBL] [Abstract][Full Text] [Related]
15. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
[TBL] [Abstract][Full Text] [Related]
16. Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.
Silva T; Mohamed T; Shakeri A; Rao PP; Martínez-González L; Pérez DI; Martínez A; Valente MJ; Garrido J; Uriarte E; Serrão P; Soares-da-Silva P; Remião F; Borges F
J Med Chem; 2016 Aug; 59(16):7584-97. PubMed ID: 27463695
[TBL] [Abstract][Full Text] [Related]
17. Catechol O-methyltransferase: characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors.
Männistö PT
Adv Pharmacol; 1998; 42():324-8. PubMed ID: 9327906
[No Abstract] [Full Text] [Related]
18. Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.
Törnwall M; Männistö PT
Eur J Pharmacol; 1993 Nov; 250(1):77-84. PubMed ID: 8119326
[TBL] [Abstract][Full Text] [Related]
19. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
20. S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase.
Lipson RS; Clarke SG
J Biol Chem; 2007 Oct; 282(42):31094-102. PubMed ID: 17724020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
